A coalition of stakeholders from across the lifecycle of medicines development has emphasised the need to bring together leadership at a global level to ensure that patient engagement becomes the norm. Members of Patient Focused Medicines Development (PFMD) have shared their views in a recent video highlighting the benefits of global collaboration in patient engagement.

PFMD member Nicola Bedlington, Secretary General at European Patients’ Forum says: “Bringing together leadership from diverse stakeholders at a global level will help to ensure that patient engagement across the lifecycle of medicines development is seen as the norm.”

Read More